Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EV/EBIT

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 43.3519.3210.3615.9722.96

What is the latest EV/EBIT ratio of NEULAND LABORATORIES ?

The latest EV/EBIT ratio of NEULAND LABORATORIES is 43.35 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202543.35
Mar202419.32
Mar202310.36
Mar202215.97
Mar202122.96

How is EV/EBIT of NEULAND LABORATORIES Trending?

Years EV/EBIT % Change
Mar2025 43.35
124.38
Mar2024 19.32
86.49
Mar2023 10.36
-35.13
Mar2022 15.97
-30.44
Mar2021 22.96 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EV/EBIT ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,709.8 Cr -4.3% -5.9% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,825.0 Cr -1.6% 5.7% 7.7% Stock Analytics
DIVIS LABORATORIES ₹161,535.0 Cr -4.2% -1.4% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,733.0 Cr -2.8% 5.7% 39.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,094.0 Cr -3.2% 1.2% 14.2% Stock Analytics
CIPLA ₹103,513.0 Cr -3.6% -3.7% -10.2% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-4.3%

-5.9%

9.7%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses